J THROMB HAEMOST - JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Publications

  1. 2024
  2. Antiplatelet drugs do not protect from platelet-leukocyte aggregation in coronary artery disease

    Schulte, C., Pieper, L., Frye, M., Waldeyer, C., Neumann, J. T., Brunner, F. J. & Pula, G., 02.2024, In: J THROMB HAEMOST. 22, 2, p. 553-557 5 p.

    Research output: SCORING: Contribution to journalShort publicationResearchpeer-review

  3. Glycolytic reprogramming fuels myeloid cell-driven hypercoagulability

    Rehill, A. M., Leon, G., McCluskey, S., Schoen, I., Hernandez-Santana, Y., Annett, S., Klavina, P., Robson, T., Curtis, A. M., Renné, T., Hussey, S., O'Donnell, J. S., Walsh, P. T. & Preston, R. J. S., 02.2024, In: J THROMB HAEMOST. 22, 2, p. 394-409 16 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. Effect of factor XI inhibition on tumor cell-induced coagulation activation

    Mäder, J., Rolling, C. C., Voigtländer, M., Schulenkorf, A., Lehr, C., Regenhardt, J., Bokemeyer, C., Beckmann, L. & Langer, F., 01.2024, In: J THROMB HAEMOST. 22, 1, p. 199-212 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. 2023
  6. Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy

    Alenazy, F. O., Harbi, M. H., Kavanagh, D. P., Price, J., Brady, P., Hargreaves, O., Harrison, P., Slater, A., Tiwari, A., Nicolson, P. L. R., Connolly, D. L., Kirchhof, P., Kalia, N., Jandrot-Perrus, M., Mangin, P. H., Watson, S. P. & Thomas, M. R., 11.2023, In: J THROMB HAEMOST. 21, 11, p. 3236-3251 16 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Glycated albumin modulates the contact system with implications for the kallikrein-kinin and intrinsic coagulation systems

    Hardy, L. J., Bohinc, D., Bane, K. L., Heal, S. L., Hethershaw, E., Ali, M., Palmer-Dench, T., Foster, R., Longstaff, C., Renné, T., Stavrou, E. X. & Philippou, H., 04.2023, In: J THROMB HAEMOST. 21, 4, p. 814-827 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. 2022
  9. Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone

    Berkowitz, S. D., Bauersachs, R. M., Szarek, M., Nehler, M. R., Debus, E. S., Patel, M. R., Anand, S. S., Capell, W. H., Hess, C. N., Hsia, J., Leeper, N. J., Brasil, D., Mátyás, L., Diaz, R., Brodmann, M., Muehlhofer, E., Haskell, L. P. & Bonaca, M. P., 05.2022, In: J THROMB HAEMOST. 20, 5, p. 1193-1205 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. A peptide from the staphylococcal protein Efb binds P-selectin and inhibits the interaction of platelets with leukocytes

    Wallis, S., Wolska, N., Englert, H., Posner, M., Upadhyay, A., Renné, T., Eggleston, I., Bagby, S. & Pula, G., 03.2022, In: J THROMB HAEMOST. 20, 3, p. 729-741 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. Targeted SERPIN (TaSER): A dual-action antithrombotic agent that targets platelets for SERPIN delivery

    Sanrattana, W., Smits, S., Barendrecht, A. D., van Kleef, N. D., El Otmani, H., Zivkovic, M., Roest, M., Renné, T., Clark, C. C., de Maat, S. & Maas, C., 02.2022, In: J THROMB HAEMOST. 20, 2, p. 353-365 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Vaccine-induced immune thrombotic thrombocytopenia (VITT) - update on diagnosis and management considering different resources: Response to Comment from Yamada et al

    Greinacher, A., Langer, F., Makris, M., Pai, M., Pavord, S., Tran, H. & Warkentin, T. E., 02.2022, In: J THROMB HAEMOST. 20, 2, p. 542-543 2 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  13. Vaccine-induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources

    Greinacher, A., Langer, F., Makris, M., Pai, M., Pavord, S., Tran, H. & Warkentin, T. E., 01.2022, In: J THROMB HAEMOST. 20, 1, p. 149-156 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. 2021
  15. Persistent Endotheliopathy in the Pathogenesis of Long COVID Syndrome

    Fogarty, H., Townsend, L., Morrin, H., Ahmad, A., Comerford, C., Karampini, E., Englert, H., Byrne, M., Bergin, C., O'Sullivan, J. M., Martin-Loeches, I., Nadarajan, P., Bannan, C., Mallon, P. W., Curley, G. F., Preston, R. J. S., Rehill, A. M., McGonagle, D., Ni Cheallaigh, C., Baker, R. I., Renné, T., Ward, S. E., O' Donnell, J. S. & Irish COVID-19 Vasculopathy Study (iCVS) investigators, 10.2021, In: J THROMB HAEMOST. 19, 10, p. 2546-2553 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. Platelet Conditioned Media Induces an Anti-inflammatory Macrophage Phenotype through EP4

    Heffron, S. P., Weinstock, A., Scolaro, B., Chen, S., Sansbury, B. E., Marecki, G., Rolling, C. C., El Bannoudi, H., Barrett, T., Canary, J. W., Spite, M., Berger, J. S. & Fisher, E. A., 02.2021, In: J THROMB HAEMOST. 19, 2, p. 562-573 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. The role of platelets in thrombus fibrosis and vessel wall remodeling after venous thrombosis

    DeRoo, E., Martinod, K., Cherpokova, D., Fuchs, T., Cifuni, S., Chu, L., Staudinger, C. & Wagner, D. D., 02.2021, In: J THROMB HAEMOST. 19, 2, p. 387-399 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. 2020
  19. Effect of myeloperoxidase on the anticoagulant activity of low-molecular-weight heparin and rivaroxaban in an in-vitro tumor model

    Voigtländer, M., Beckmann, L., Schulenkorf, A., Sievers, B., Rolling, C., Bokemeyer, C. & Langer, F., 12.2020, In: J THROMB HAEMOST. 18, 12, p. 3267-3279 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Fibrillar amyloid peptides promote platelet aggregation through the coordinated action of itam- and ros-dependent pathways

    Visconte, C., Canino, J., Vismara, M., Francesco Guidetti, G., Raimondi, S., Pula, G., Torti, M. & Canobbio, I., 11.2020, In: J THROMB HAEMOST. 18, 11, p. 3029-3042 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Comparison of von Willebrand factor platelet-binding activity assays: ELISA overreads type 2B with loss of HMW multimers

    Szederjesi, A., Baronciani, L., Budde, U., Castaman, G., Colpani, P., Lawrie, A. S., Liu, Y., Montgomery, R., Peyvandi, F., Schneppenheim, R., Patzke, J. & Bodó, I., 10.2020, In: J THROMB HAEMOST. 18, 10, p. 2513-2523 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study

    Tosetto, A., Badiee, Z., Baghaipour, M-R., Baronciani, L., Battle, J., Berntorp, E., Bodó, I., Budde, U., Castaman, G., Eikenboom, J. C. J., Eshghi, P., Ettorre, C., Goodeve, A., Goudemand, J., Hay, C. R. M., Hoorfar, H., Karimi, M., Keikhaei, B., Lassila, R., Leebeek, F. W. G., Lopez Fernandez, M. F., Mannucci, P. M., Mazzucconi, M. G., Morfini, M., Oldenburg, J., Peake, I., Parra Lòpez, R., Peyvandi, F., Schneppenheim, R., Tiede, A., Toogeh, G., Trossaert, M., Zekavat, O., Zetterberg, E. M. K. & Federici, A. B., 09.2020, In: J THROMB HAEMOST. 18, 9, p. 2145-2154 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Vps34 derived phosphatidylinositol 3-monophosphate modulates megakaryocyte maturation and proplatelet production through late endosomes/lysosomes

    Bertović, I., Kurelić, R., Milošević, I., Bender, M., Krauss, M., Haucke, V. & Jurak Begonja, A., 07.2020, In: J THROMB HAEMOST. 18, 7, p. 1756-1772 17 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Cross-reacting inhibitors against recombinant porcine factor VIII in acquired hemophilia A: Data from the GTH-AH 01/2010 Study

    Türkantoz, H., Königs, C., Knöbl, P., Klamroth, R., Holstein, K., Huth-Kühne, A., Heinz, J., Eichler, H. & Tiede, A., 01.2020, In: J THROMB HAEMOST. 18, 1, p. 36-43 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. 2019
  26. Nomenclature of factor XI and the contact system

    Schmaier, A. H., Emsley, J., Feener, E. P., Gailani, D., Govers-Riemslag, J. W. P., Kaplan, A. P., Maas, C., Morrissey, J. H., Renné, T., Sidelmann, J. J. & Meijers, J. C. M., 12.2019, In: J THROMB HAEMOST. 17, 12, p. 2216-2219 4 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. International Society on Thrombosis and Haemostasis core curriculum project: core competencies in laboratory thrombosis and hemostasis

    Moffat, K. A., Kiencke, V., Blanco, A. N., McLintock, C., Peyvandi, F., de Maat, M. P. M., Adams, M. J., Angchaisuksiri, P., Nair, S., Tsuda, H., Haddad, M., Renné, T., Clark, R. C. & Ross, M. T., 11.2019, In: J THROMB HAEMOST. 17, 11, p. 1848-1859 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. 2018
  29. What a drag - necrotic platelets induce remote neutrophil thrombi following ischemic gut injury

    Martinod, K. & Fuchs, T. A., 05.2018, In: J THROMB HAEMOST. 16, 5, p. 819-821 3 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  30. 2016
  31. Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism

    Dennis, J., Truong, V., Aïssi, D., Medina-Rivera, A., Blankenberg, S., Germain, M., Lemire, M., Antounians, L., Civelek, M., Schnabel, R., Wells, P., Wilson, M. D., Morange, P-E., Trégouët, D-A. & Gagnon, F., 10.2016, In: J THROMB HAEMOST. 14, 10, p. 1960-1970 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Identification and characterization of the elusive mutation causing the historical von Willebrand Disease type IIC Miami

    Obser, T., Ledford-Kraemer, M., Oyen, F., Brehm, M. A., Denis, C. V., Marschalek, R., Montgomery, R. R., Sadler, J. E., Schneppenheim, S., Budde, U. & Schneppenheim, R., 09.2016, In: J THROMB HAEMOST. 14, 9, p. 1725-35 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study

    Werwitzke, S., Geisen, U., Nowak-Göttl, U., Eichler, H., Stephan, B., Scholz, U., Holstein, K., Klamroth, R., Knöbl, P. N., Huth-Kühne, A., Bomke, B. & Tiede, A., 05.2016, In: J THROMB HAEMOST. 14, 5, p. 940-7 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Contact system revisited: an interface between inflammation, coagulation, and innate immunity

    Long, A. T., Kenne, E., Jung, R., Fuchs, T. A. & Renné, T., 03.2016, In: J THROMB HAEMOST. 14, 3, p. 427-37 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. The Alzheimer's disease peptide Aβ promotes thrombin generation through activation of coagulation factor XII

    Zamolodchikov, D., Renné, T. & Strickland, S., 2016, In: J THROMB HAEMOST. 14, 5, p. 995-1007

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. 2015
  37. Platelet dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH

    Bodó, I., Eikenboom, J., Montgomery, R., Patzke, J., Schneppenheim, R., Di Paola, J. & Subcommittee on von Willebrand factor, 07.2015, In: J THROMB HAEMOST. 13, 7, p. 1345-1350

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. Impaired DNase1-mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies

    Jiménez-Alcázar, M., Napirei, M., Panda, R., Köhler, E. C., Kremer Hovinga, J. A., Mannherz, H. G., Peine, S., Renné, T., Lämmle, B. & Fuchs, T. A., 05.2015, In: J THROMB HAEMOST. 13, 5, p. 732-42 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. 2012
  40. Neutrophil extracellular traps promote deep vein thrombosis in mice

    Brill, A., Fuchs, T. A., Savchenko, A. S., Thomas, G. M., Martinod, K., De Meyer, S. F., Bhandari, A. A. & Wagner, D. D., 01.01.2012, In: J THROMB HAEMOST. 10, 1, p. 136-44 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa.

    Van Der Meijden, P. E. J., Van Schilfgaarde, M., Van Oerle, R., Renné, T., Ten Cate, H. & Spronk, H. M. H., 2012, In: J THROMB HAEMOST. 10, 7, p. 1355-1362 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. Reduced von Willebrand factor secretion is associated with loss of Weibel-Palade body formation.

    Castaman, G., Giacomelli, S. H., Jacobi, P. M., Obser, T., Budde, U., Rodeghiero, F., Schneppenheim, R. & Haberichter, S. L., 2012, In: J THROMB HAEMOST. 10, 5, p. 951-958 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. 2011
  44. A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study).

    Gringeri, A., Lundin, B., Mackensen von, S., Mantovani, L., Mannucci, P. M. & Group, ESPRIT. S., 2011, In: J THROMB HAEMOST. 9, 4, p. 700-710 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population.

    Mohl, A., Boda, Z., Jager, R., Losonczy, H., Marosi, A., Masszi, T., Nagy, E., Nemes, L., Obser, T., Oyen, F., Radványi, G., Schlammadinger, U., Szélessy, Z. S., Várkonyi, A., Vezendy, K., Vilimi, B., Schneppenheim, R. & Bodó, I., 2011, In: J THROMB HAEMOST. 9, 5, p. 945-952 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients.

    Hollestelle, M. J., Loots, C. M., Squizzato, A., Renné, T., Bouma, B. J., de Groot, P. G., Lenting, P. J., Meijers, J. C. M. & Gerdes, V. E. A., 2011, In: J THROMB HAEMOST. 9, 5, p. 953-958 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. Factor XII activation is essential to sustain the procoagulant effects of particulate matter.

    Kilinç, E., Van Oerle, R., Borissoff, J. I., Oschatz, C., Gerlofs-Nijland, M. E., Janssen, N. A., Cassee, F. R., Sandström, T., Renné, T., Ten Cate, H. & Spronk, H. M. H., 2011, In: J THROMB HAEMOST. 9, 7, p. 1359-1367 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein.

    Schneppenheim, R. & Budde, U., 2011, In: J THROMB HAEMOST. 9 Suppl 1, p. 209-215

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. 2010
  50. Homozygous type 2N R854W von Willebrand factor is poorly secreted and causes a severe von Willebrand disease phenotype

    Castaman, G., Giacomelli, S. H., Jacobi, P., Obser, T., Budde, U., Rodeghiero, F., Haberichter, S. L. & Schneppenheim, R., 09.2010, In: J THROMB HAEMOST. 8, 9, p. 2011-6 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. von Willebrand factor variant p.Arg924Gln marks an allele associated with reduced von Willebrand factor and factor VIII levels

    Hickson, N., Hampshire, D., Winship, P., Goudemand, J., Schneppenheim, R., Budde, U., Castaman, G., Rodeghiero, F., Federici, A. B., James, P., Peake, I., Eikenboom, J., Goodeve, A. & MCMDM-1VWD and ZPMCB-VWD study groups, 09.2010, In: J THROMB HAEMOST. 8, 9, p. 1986-1993 8 p., 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. Homozygous type 2N R854W von Willebrand factor is poorly secreted and causes a severe von Willebrand disease phenotype.

    Castaman, G., Giacomelli, S. H., Jacobi, P., Obser, T., Budde, U., Rodeghiero, F., Haberichter, S. L. & Schneppenheim, R., 2010, In: J THROMB HAEMOST. 8, 9, p. 2011-2016 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. Redox-generated isoprostanes are associated with residual platelet activity in aspirin-treated patients with stable coronary heart disease.

    Schwedhelm, E., Bierend, A., Maas, R., Trinks, R., Kom, G. D., Tsikas, D. & Böger, R., 2010, In: J THROMB HAEMOST. 8, 12, p. 2662-2670 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  54. 2009
  55. Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study

    Eikenboom, J., Hilbert, L., Ribba, A. S., Hommais, A., Habart, D., Messenger, S., Al-Buhairan, A., Guilliatt, A., Lester, W., Mazurier, C., Meyer, D., Fressinaud, E., Budde, U., Will, K., Schneppenheim, R., Obser, T., Marggraf, O., Eckert, E., Castaman, G., Rodeghiero, F., Federici, A. B., Batlle, J., Goudemand, J., Ingerslev, J., Lethagen, S., Hill, F., Peake, I. & Goodeve, A., 08.2009, In: J THROMB HAEMOST. 7, 8, p. 1304-12 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  56. Factor XI deficiency in animal models

    Renné, T., Oschatz, C., Seifert, S., Müller, F., Antovic, J., Karlman, M. & Benz, P. M., 01.07.2009, In: J THROMB HAEMOST. 7 Suppl 1, p. 79-83 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  57. Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy

    Siboni, S. M., Mannucci, P. M., Gringeri, A., Franchini, M., Tagliaferri, A., Ferretti, M., Tradati, F. C., Santagostino, E., von Mackensen, S. & Italian Association of Haemophilia Centres (AICE), 05.2009, In: J THROMB HAEMOST. 7, 5, p. 780-6 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  58. Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study

    Tregouet, D. A., Schnabel, R., Alessi, M. C., Godefroy, T., Declerck, P. J., Nicaud, V., Munzel, T., Bickel, C., Rupprecht, H. J., Lubos, E., Zeller, T., Juhan-Vague, I., Blankenberg, S., Tiret, L., Morange, P. E. & AtheroGene Investigators, 01.2009, In: J THROMB HAEMOST. 7, 1, p. 49-57 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  59. Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice.

    Meyer, T., Robles-Carrillo, L., Robson, T., Langer, F., Desai, H., Davila, M., Amaya, M., Francis, J. L. & Amirkhosravi, A., 2009, In: J THROMB HAEMOST. 7, 1, p. 171-181 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  60. Development of targeted angiogenic medicine.

    Loges, S., Roncal, C. & Carmeliet, P., 2009, In: J THROMB HAEMOST. 7, 1, p. 21-33 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  61. Expression of fourteen von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study.

    Eikenboom, J., Hilbert, L., Ribba, A. S., Hommais, A., Habart, D., Messenger, S., Al-Buhairan, A., Guilliatt, A., Lester, W., Mazurier, C., Meyer, D., Fressinaud, E., Budde, U., Will, K., Schneppenheim, R., Obser, T., Marggraf, O., Eckert, E., Castaman, G., Rodeghiero, F., Federici, A. B., Batlle, J., Goudemand, J., Ingerslev, J., Lethagen, S., Oyen, F., Peake, I. & Goodeve, A., 2009, In: J THROMB HAEMOST.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  62. Shear-induced unfolding activates von Willebrand factor A2 domain for proteolysis.

    Schneppenheim, R., Baldauf, C., Stacklies, W., Obser, T., Pieconka, A., Schneppenheim, S., Budde, U., Zhou, J. & Gräter, F., 2009, In: J THROMB HAEMOST. 7, 12, p. 2096-2105 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Previous 1 2 Next